Oral rivaroxaban for the treatment of symptomatic venous thromboembolism in 400 patients with active cancer: a single-center experience - Pignataro, B S; Nishinari, K; Cavalcante, R N (Clin Appl Thromb Hemost, 2017)
, et al.